ICMB vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ICMB exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a technical trend of 0/100. While the stock trades at a deep discount to book value (P/B 0.40), this is likely a value trap given the negative ROE (-12.74%) and a catastrophic Q/Q revenue decline of -1331.16%. The dividend yield of 30.23% is fundamentally unsustainable with a payout ratio of 160%, indicating the company is returning more capital than it earns. Consistent earnings misses (0/4 in the last year) further signal a deteriorating operational trajectory.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
ICMB vs JPM: Head-to-Head Comparison
This page compares Investcorp Credit Management BDC, Inc. (ICMB) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.